The Michigan State Medical Society Foundation presents:
The ASAM Treatment of Opioid Use Disorder Course
Saturday, October 27, 2018
8:00 am - 12:30 pm
The Sheraton Detroit-Novi
21111 Haggerty Road
Novi, MI 48375
This course covers all medications and treatments for opioid use disorder. This course also provides eight hours of required education* to obtain the waiver to prescribe buprenorphine by using interactive, case-based learning to teach evidence-based practices.
- Physicians, nurse practitioners, and physician assistants who wish to obtain a waiver to prescribe buprenorphine in office-based treatment of opioid use disorders.
- Clinicians and healthcare team members working with physicians who prescribe buprenorphine in office-based treatment of opioid use disorders.
You will learn how to:
- Summarize the clinical pharmacology, efficacy, and safety of methadone, buprenorphine, and naltrexone in treating opioid use disorders
- Identify and assess patients who are appropriate for treatment with medications for an opioid use disorder in an office-based setting
- Describe procedures for initiating, stabilizing, maintaining, monitoring, and modifying treatment of patients on buprenorphine or naltrexone
- Summarize the assessment and management of patients with psychiatric and medical co-morbidities associated with opioid use disorders
- Describe unique issues of treating adolescents, young adults, pregnant, and postpartum patients maintained on medications for opioid use disorders
- Apply for a waiver to prescribe buprenorphine to patients with opioid use disorder
This is an 8-hour blended course combining 4 hours of online learning followed by 4 hours of live learning. Registration will give you access to the online portion of the course.
This course also meets LARA's requirement for 3 hours of continuing medical education in pain and symptom management.
In addition, for physicians participating in the BCN HMO Commercial Network, primary care providers who obtain a buprenorphine waiver between February 5 - December 31, 2018, in targeted counties are eligible to receive $1,500 through the Medication Assisted Treatment Reward. This incentive applies only to providers who currently do not have a buprenorphine waiver. Participating counties include: Arenac, Bay, Cherlevoix, Cheboygan, Clare, Crawford, Delta, Emmet, Gladwin, Gogebic, Huron, Iosco, Isabella, Lake, Mackinac, Manistee, Mason, Mecosta, Menominee, Midland, Montmorency, Ogemaw, Oscoda, Roscommon, Saginaw.
We hope you can join us!
To register for this and other courses at the 153rd Annual Scientific Meeting, please visit www.msms.org/ASM
The American Society of Addiction Medicine (ASAM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Society of Addiction Medicine designates this enduring material for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
The American Society of Addiction Medicine designates this live activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.